Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byAmgen
Price$380M
Date10/2008
TermsCash

General Information

Websiteavidia.com
CategoryBioTech
Phone650-404-2000
Employees
Founded2003
Descriptionbiopharmaceutical company

Offices

HQ
2450 Bayshore Parkway
2nd Floor
Mountain View, CA, 94043
USA

Funding

Tags

Avidia

Avidia, Inc., a biopharmaceutical company, engages in discovering and developing therapeutic proteins. The company offers Avimer therapeutic proteins, which are used to address various therapeutic areas, including autoimmunity, inflammation, oncology, and neurology. Avidia, Inc. was founded in 2003 and is headquartered in Mountain View, California.

Recent Milestones

Videos

Screenshots

Avidia screenshot
Above: Avidia Screenshot -- #1
Uploaded: 4/9/14

Sources

  1. Amgen to buy inflammation drug co. Avidia for up to $380M (deals.venturebeat.com) [edit]
  2. AVIDIA ADVANCING LEAD PRODUCT THROUGH $28.5M SERIES B ROUND. (thefreelibrary.com) [edit]
  3. AVIDIA RAISES $43.8 MILLION TO ADVANCE NEW CLASS OF PHARMACEUTICALS (freshnews.com) [edit]
Edit This Page
Last Edited 4/8/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy